Uterine Cancer Awareness Month: Resources & More

Uterine (or endometrial) cancer is the most common type of gynecologic cancer, with more than 886,000 women living with the disease in the U.S., according to National Cancer Institute’s SEER Cancer Statistics. As Ovarian Cancer Research Alliance funds research that aims to cure ovarian and related gynecologic cancers, we are here for those impacted by uterine/endometrial cancer.

Support programs for uterine cancer patients and caregivers

Weekly Series:
Staying Connected: Endometrial & Uterine Cancer
Mondays at 3PM ET
Register here.

In addition to our weekly sessions, OCRA offers special programming for the uterine/endometrial cancer community throughout the year.

Educational Uterine Cancer Videos

OCRA is addressing disparities for uterine and endometrial cancer patients

While mortality and incidence rates for ovarian cancer are steadily improving, the same is not true for uterine/endometrial cancer. 2025 statistics from the American Cancer Society show that uterine/endometrial cancer is now the leading cause of gynecologic cancer deaths, with mortality rising by 1.5% every year, and incidence rates rising more than 1% yearly. Further, there are deep disparities in both incidence and survival, as Black women are more likely to be diagnosed with uterine/endometrial cancer, and experience worse outcomes.

OCRA is supporting research to address these critical issues. Dr. Caroline Thompson, The University of North Carolina at Chapel Hill, a 2025 Health Equity Research Grant Recipient, is investigating delays in referral to diagnosis for ovarian and uterine cancer, with a focus on Black patients in North Carolina. Her goal is to support evidence and interventions that will improve earlier diagnosis and reduce outcome disparities for these cancer types.

Ovarian Cancer Research Alliance is here for everyone impacted by uterine cancer. Explore our support services and reach out.